Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment

Detalles Bibliográficos
Autores principales: Westhovens, R, van Riel, P, Sibilia, J, Vratsanos, G, Nuamah, I, Becker, JC
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833769/
http://dx.doi.org/10.1186/ar1128
_version_ 1782178464401457152
author Westhovens, R
van Riel, P
Sibilia, J
Vratsanos, G
Nuamah, I
Becker, JC
author_facet Westhovens, R
van Riel, P
Sibilia, J
Vratsanos, G
Nuamah, I
Becker, JC
author_sort Westhovens, R
collection PubMed
description
format Text
id pubmed-2833769
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28337692010-03-08 Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment Westhovens, R van Riel, P Sibilia, J Vratsanos, G Nuamah, I Becker, JC Arthritis Res Ther Meeting Abstract BioMed Central 2004 2004-02-24 /pmc/articles/PMC2833769/ http://dx.doi.org/10.1186/ar1128 Text en
spellingShingle Meeting Abstract
Westhovens, R
van Riel, P
Sibilia, J
Vratsanos, G
Nuamah, I
Becker, JC
Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
title Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
title_full Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
title_fullStr Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
title_full_unstemmed Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
title_short Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
title_sort abatacept (ctla4ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833769/
http://dx.doi.org/10.1186/ar1128
work_keys_str_mv AT westhovensr abataceptctla4igtreatmentincreasestheremissionrateinrheumatoidarthritispatientsrefractorytomethotrexatetreatment
AT vanrielp abataceptctla4igtreatmentincreasestheremissionrateinrheumatoidarthritispatientsrefractorytomethotrexatetreatment
AT sibiliaj abataceptctla4igtreatmentincreasestheremissionrateinrheumatoidarthritispatientsrefractorytomethotrexatetreatment
AT vratsanosg abataceptctla4igtreatmentincreasestheremissionrateinrheumatoidarthritispatientsrefractorytomethotrexatetreatment
AT nuamahi abataceptctla4igtreatmentincreasestheremissionrateinrheumatoidarthritispatientsrefractorytomethotrexatetreatment
AT beckerjc abataceptctla4igtreatmentincreasestheremissionrateinrheumatoidarthritispatientsrefractorytomethotrexatetreatment

Ejemplares similares